A Survivor’s Take on Cancer Drugs and the “Moonshot”
Here’s why you should support innovation in pharmaceuticals: it’s the path to a cure.
For the first half of my life, cancer was something I never thought about. Then, after being diagnosed with Hodgkin’s Lymphoma at 17, it became the thing that shocked me, that I overcame, that I feared returning, and eventually that shaped my career. I’m not only a cancer survivor; I’m also a health economist and health policy expert focusing on innovative cancer drugs and patient access to medicines.
We need a cancer moonshot.
We can achieve a cancer moonshot by investing in science.
But — we will never achieve a moonshot if the public, politicians, and media continue to bash pharma and biotech companies instead of recognizing that they are the innovation engines driving cancer’s cures.
